This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Shaker M, Lobb A, Jenkins P, O'Rourke D, Takemoto SK, Sheth S, Burroughs T, Dykewicz MS.An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease. Journal of Allergy and Clinical Immunology 121: 81-87, No. 1, Jan 2008
Rights and permissions
About this article
Cite this article
Aspirin desensitisation cost effective for AERD. Pharmacoecon. Outcomes News 548, 7 (2008). https://doi.org/10.2165/00151234-200805480-00016
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805480-00016